These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 32231233)

  • 1. Publisher Correction: Circulating serum HBsAg level is a biomarker for HBV-specific T and B cell responses in chronic hepatitis B patients.
    Kim JH; Ghosh A; Ayithan N; Romani S; Khanam A; Park JJ; Rijnbrand R; Tang L; Sofia MJ; Kottilil S; Moore CB; Poonia B
    Sci Rep; 2020 Mar; 10(1):5947. PubMed ID: 32231233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating serum HBsAg level is a biomarker for HBV-specific T and B cell responses in chronic hepatitis B patients.
    Kim JH; Ghosh A; Ayithan N; Romani S; Khanam A; Park JJ; Rijnbrand R; Tang L; Sofia MJ; Kottilil S; Moore CB; Poonia B
    Sci Rep; 2020 Feb; 10(1):1835. PubMed ID: 32020034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T- and B-cell responses and previous exposure to hepatitis B virus in 'anti-HBc alone' patients.
    Wang Q; Sachse P; Semmo M; Lokhande M; Montani M; Dufour JF; Zoulim F; Klenerman P; Semmo N
    J Viral Hepat; 2015 Dec; 22(12):1068-78. PubMed ID: 26075501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PreS antigen expression and anti-preS response in hepatitis B virus infections: relationship to serum HBV-DNA, intrahepatic HBcAg, liver damage and specific T-cell response.
    Petit MA; Capel F; Zoulim F; Dubanchet S; Chemin I; Penna A; Ferrari C; Trépo C
    Arch Virol Suppl; 1992; 4():105-12. PubMed ID: 1280500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of amino acid substitutions in hepatitis B virus surface protein on virion secretion, antigenicity, HBsAg and viral DNA.
    Xiang KH; Michailidis E; Ding H; Peng YQ; Su MZ; Li Y; Liu XE; Dao Thi VL; Wu XF; Schneider WM; Rice CM; Zhuang H; Li T
    J Hepatol; 2017 Feb; 66(2):288-296. PubMed ID: 27650283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum Hepatitis B Virus DNA, RNA, and HBsAg: Which Correlated Better with Intrahepatic Covalently Closed Circular DNA before and after Nucleos(t)ide Analogue Treatment?
    Gao Y; Li Y; Meng Q; Zhang Z; Zhao P; Shang Q; Li Y; Su M; Li T; Liu X; Zhuang H
    J Clin Microbiol; 2017 Oct; 55(10):2972-2982. PubMed ID: 28747369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-12-based vaccination therapy reverses liver-induced systemic tolerance in a mouse model of hepatitis B virus carrier.
    Zeng Z; Kong X; Li F; Wei H; Sun R; Tian Z
    J Immunol; 2013 Oct; 191(8):4184-93. PubMed ID: 24048897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers.
    Thompson AJ; Nguyen T; Iser D; Ayres A; Jackson K; Littlejohn M; Slavin J; Bowden S; Gane EJ; Abbott W; Lau GK; Lewin SR; Visvanathan K; Desmond PV; Locarnini SA
    Hepatology; 2010 Jun; 51(6):1933-44. PubMed ID: 20512987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Publisher Correction: Regulation of the Hepatitis B virus replication and gene expression by the multi-functional protein TARDBP.
    Makokha GN; Abe-Chayama H; Chowdhury S; Hayes CN; Tsuge M; Yoshima T; Ishida Y; Zhang Y; Uchida T; Tateno C; Akiyama R; Chayama K
    Sci Rep; 2020 Feb; 10(1):2233. PubMed ID: 32024922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B virus (HBV) antigen-pulsed monocyte-derived dendritic cells from HBV-associated hepatocellular carcinoma patients significantly enhance specific T cell responses in vitro.
    Shi M; Qian S; Chen WW; Zhang H; Zhang B; Tang ZR; Zhang Z; Wang FS
    Clin Exp Immunol; 2007 Feb; 147(2):277-86. PubMed ID: 17223969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relationship between hepatitis B surface antigen, HBV DNA quantity and liver fibrosis severity].
    Gao Y; Zou G; Ye J; Pan G; Rao J; Li F; Wei Y; Li X
    Zhonghua Gan Zang Bing Za Zhi; 2015 Apr; 23(4):254-7. PubMed ID: 26133815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Publisher Correction: Liver sinusoidal endothelial cells (LSECs) modifications in patients with chronic hepatitis C.
    Baiocchini A; Del Nonno F; Taibi C; Visco-Comandini U; D'Offizi G; Piacentini M; Falasca L
    Sci Rep; 2020 Jan; 10(1):1420. PubMed ID: 31980700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B Virus Surface Antigen Activates Myeloid Dendritic Cells via a Soluble CD14-Dependent Mechanism.
    van Montfoort N; van der Aa E; van den Bosch A; Brouwers H; Vanwolleghem T; Janssen HLA; Javanbakht H; Buschow SI; Woltman AM
    J Virol; 2016 Jul; 90(14):6187-6199. PubMed ID: 27099316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody-mediated immunotherapy against chronic hepatitis B virus infection.
    Gao Y; Zhang TY; Yuan Q; Xia NS
    Hum Vaccin Immunother; 2017 Aug; 13(8):1768-1773. PubMed ID: 28521640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of circulating miR-122 in patients with dual chronic hepatitis B and C virus infection.
    Cheng HR; Kao JH; Wu HL; Tseng TC; Liu CH; Yang HC; Su TH; Chen PJ; Chen DS; Liu CJ
    Hepatol Int; 2015 Jan; 9(1):35-42. PubMed ID: 25788377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decades after recovery from hepatitis B and HBsAg clearance the CD8+ T cell response against HBV core is nearly undetectable.
    Kefalakes H; Jochum C; Hilgard G; Kahraman A; Bohrer AM; El Hindy N; Heinemann FM; Verheyen J; Gerken G; Roggendorf M; Timm J
    J Hepatol; 2015 Jul; 63(1):13-9. PubMed ID: 25646888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B surface antigen quantification: why and how to use it in 2011 - a core group report.
    Chan HL; Thompson A; Martinot-Peignoux M; Piratvisuth T; Cornberg M; Brunetto MR; Tillmann HL; Kao JH; Jia JD; Wedemeyer H; Locarnini S; Janssen HL; Marcellin P
    J Hepatol; 2011 Nov; 55(5):1121-31. PubMed ID: 21718667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of intrahepatic total HBV DNA, cccDNA and serum HBsAg level in Chronic Hepatitis B patients with undetectable serum HBV DNA during oral antiviral therapy.
    Li J; Sun X; Fang J; Wang C; Han G; Ren W
    Clin Res Hepatol Gastroenterol; 2017 Dec; 41(6):635-643. PubMed ID: 28438570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum hepatitis B surface antigen correlates with tissue covalently closed circular DNA in patients with hepatitis B-associated hepatocellular carcinoma.
    Wang Q; Luan W; Warren L; Fiel MI; Blank S; Kadri H; Tuvin D; Hiotis SP
    J Med Virol; 2016 Feb; 88(2):244-51. PubMed ID: 26174662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progression and status of antiviral monitoring in patients with chronic hepatitis B: From HBsAg to HBV RNA.
    Liu YY; Liang XS
    World J Hepatol; 2018 Sep; 10(9):603-611. PubMed ID: 30310538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.